HIGHLIGHTS
- who: Report from the Rheumatology, Albany Stratton VA Medical Center, Albany, USA have published the research: Review began 10/25/2022 Review ended 11/28/2022 Published 11/30/2022 u00a9 Copyright, in the Journal: (JOURNAL) of November/30,/2022
- what: The authors report here an adult male with post-COVID-19 inflammatory syndrome, who displayed robust clinical improvement with an interleukin-1B (IL-1B) inhibitor, anakinra monotherapy.
SUMMARY
Multisystem inflammatory syndrome (MIS) is a severe inflammatory response, days to weeks following the infection of severe acute respiratory syndrome coronavirus 2 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.